Who backs Sparrow Pharmaceuticals?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Keiretsu Forum | Other |
| Matter (Consulting Services (B2B)) | Other |
| OrbiMed | Growth equity |
| Forbion | Venture capital |
| Business Oregon | Other |
| Chicago ArchAngels | — |
| Oregon Bioscience Incubator | — |
| RiverVest Venture Partners | — |
| Slojo Investments | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Sparrow Pharmaceuticals investors
11 investors are on record for Sparrow Pharmaceuticals, including RA Capital Management, Keiretsu Forum, Matter (Consulting Services (B2B)) and OrbiMed. The Series B in Sep 2025 drew 4 investors.
Free account
More of Sparrow Pharmaceuticals with a free account
- ·The complete investor list: 11 names
- ·Watch Sparrow Pharmaceuticals: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Sparrow Pharmaceuticals in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View